Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 12.06 is 24% above its 5-year average of 9.74, around the middle of its 5-year range (0.27–26.53).
As of the fiscal period ended Tuesday, June 30, 2026. 0.85% above its 12-month average of 11.96.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.06.
CURRENT RATIO
12.06
CURRENT RATIO AVG TTM
11.96
CURRENT RATIO AVG 3Y
13.68
CURRENT RATIO AVG 5Y
9.74
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.85%
CURRENT VS 3Y AVG
-11.85%
CURRENT VS 5Y AVG
+23.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.57
median of 739 covered companies
CURRENT VS SECTOR MEDIAN
+237.77%
vs the sector median at left
Market Cap
$5.77M
Current Ratio
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$5.98M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
Market Cap
$5.63M
Current Ratio
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$6.02M
Current Ratio
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$5.60M
Current Ratio
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
Market Cap
$6.43M
Current Ratio
0.70
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.04
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucyd, Inc (LUCY) | $5.85M | 12.06 | 11.96 | 13.68 | 9.74 |
| Scienture Holdings, Inc. (SCNX)vs › | $6.10M | 3.04 | 1.85 | 1.23 | 3.43 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | 2.35 | 1.31 | 0.84 | 0.78 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.98M | 119.39 | 100.04 | 53.39 | 40.10 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.02M | 17.15 | 11.86 | 7.50 | 9.06 |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | 11.70 | 17.23 | 23.62 | 22.05 |
| Femasys Inc. (FEMY)vs › | $6.16M | 2.14 | 2.73 | 5.58 | 6.46 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | 0.70 | 2.00 | 1.31 | 1.04 |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 3.01 | 3.95 | 2.52 | 4.28 |
Current Ratio
12.06
Quick Ratio
11.25
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 12.06 |
| 2026-03-31 | 8.02 |
| 2025-12-31 | 9.03 |
| 2025-09-30 | 11.98 |
| 2025-06-30 | 18.70 |
| 2025-03-31 | 16.39 |
| 2024-12-31 | 12.52 |
| 2024-09-30 | 16.83 |
| 2024-06-30 | 14.73 |
| 2024-03-31 | 4.65 |
| 2023-12-31 | 8.99 |
| 2023-09-30 | 17.40 |
| 2023-06-30 | 26.53 |
| 2023-03-31 | 9.00 |
| 2022-12-31 | 7.07 |
| 2022-09-30 | 7.17 |
| 2022-06-30 | 0.27 |
| 2022-03-31 | 0.39 |
| 2021-12-31 | 1.04 |
| 2021-09-30 | 0.75 |
| 2021-06-30 | 0.97 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.19 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
